About 200 reports

  • BIOSIMILARS
  • Biosimilar Process
  • Biopharmaceutical
  • Biosimilar
  • World
  • Market Size
  • Remicade group
  • BIOCON - MAJOR BIOSIMILARS IN PIPELINE
  • BIOSIMILARS MARKET - BY APPLICATIONS
  • Biosimilar
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited
  • Biosimilar
  • Biosimilars
  • Biosimilar
  • China
  • Forecast
  • Amgen Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • US Approved Biosimilars
  • 2.3 Overview of Biosimilars
  • Biosimilar
  • Amgen Inc.
  • Celltrion, Inc.
  • Pfizer Inc.
  • Sandoz Inc.
  • 6.3 BIOSIMILARS ASSESSMENT
  • BIOSIMILAR LEGISLATIONS ACROSS THE 8MM
  • Biosimilar
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • Remicade group
  • Biosimilars: Overview
  • Emergence of biosimilars
  • Biosimilar
  • Biocon Limited
  • Hospira, Inc.
  • Sandoz Inc.
  • Teva Pharmaceuticals Ltd.
  • 2.3 BIOSIMILARS OVERVIEW
  • US Approved Biosimilars
  • Biosimilar
  • World
  • Boehringer Ingelheim GmbH
  • Lonza Group Ltd
  • Samsung Electronics Co., Ltd.

##. ## What are Biosimilars?

  • Biopharmaceutical
  • Biosimilar
  • Europe
  • World
  • Market Size

##. ##. ## Biosimilar Infliximab: Currently the Second Largest Submarket ##. ##. ##. ## Biosimilar Infliximab Revenue Forecast 2016-2027 ##. ##. ## Biosimilar Rituximab: The Current Leading Submarket Driven by Sales in Russia ##. ##. ##. ## Biosimilar Rituximab: Revenue Forecast 2016-##

  • Biosimilar
  • Monoclonal Antibody
  • Therapy
  • World
  • Market Size

Biosimilars Market Snapshot Table ## Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025 Table ## Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025 Table ## Global Oncology Biosimilars Marke

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World
  • Market Size

Global Biosimilars Industry I.

  • Biopharmaceutical
  • Biosimilar
  • Europe
  • United States
  • World
  • Applicants have the right of reference to essential investigations
  • EMERGENCE OF NEXT-GENERATION BIOLOGICS SHOULD LEAD THE GROWTH CHART
  • Biosimilar
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • European Biosimilar Market - Immunomodulator -
  • Middle East & Africa Biosimilars Market - Immunomodulators -
  • Biosimilar
  • Biocon Limited
  • Hospira, Inc.
  • Mylan Inc.
  • Sandoz Inc.

Global Biosimilar Market Outlook 2022 ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World
  • Market Size
  • SANDOZ ACQUIRES RIGHTS OF BIOSIMILAR INFLIXIMAB FROM PFIZER
  • FEB 11, 2016: SANDOZ ADVANCES ITS BIOSIMILARS PROGRAM WITH EMA ACCEPTANCE OF REGULATORY SUBMISSION FOR BIOSIMILAR PEGFILGRASTIM
  • Biosimilar
  • GlobalData's company
  • Nipro Corporation
  • Novartis AG
  • Sandoz Inc.

Reddy' s Laboratories - Hospira - Other prominent vendors PART ##: Appendix - List of abbreviations PART ##: Explore Technavio List of Exhibits Exhibit ##: Product offerings Exhibit ##: Global mAb biosimilars market: Snapshot Exhibit ##: Global mAb biosimilars market: Growth

  • Biosimilar
  • Monoclonal Antibody
  • Therapy
  • World
  • Market Size
  • 8.5 BIOSIMILAR PIPELINE PRODUCTS
  • 8.5.3 BIOSIMILARS IN THE IMMUNOLOGY COMMUNITY
  • Biosimilar
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • PROVIDES A SWOT ANALYSIS FOR BIOSIMILARS.
  • BIOSIMILARS SWOT ANALYSIS, 2015
  • Biosimilar
  • Epidemiology
  • Europe
  • Pfizer Inc.
  • Remicade group

Biosimilars Real World Evidence: Proving the point ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Europe
  • PRODUCT PROFILE - INSULIN GLARGINE BIOSIMILARS
  • PRESENTS A PRODUCT PROFILE OF INSULIN GLARGINE BIOSIMILARS
  • Biosimilar
  • Europe
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

Biosimilars Market Access in the U. S. ## EXECUTIVE SUMMARY ## Regulatory pathway ## Substitution and naming ## Legal considerations ## Pricing, reimbursement, and access ## Education needs ## THE NEED FOR BIOSIMILARS ## What are biosimilars?

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • United States
  • Forecast

This report analyzes the global markets for " Biosimilar Drugs".

  • Biosimilar
  • Asia
  • Europe
  • North America
  • World

Reddy' s Laboratories - F Hoffmann-La Roche - Hospira - Mylan - Sandoz - Other prominent vendors PART ##: Appendix - List of abbreviations PART ##: Explore Technavio List of Exhibits Exhibit ##: Product offerings Exhibit ##: Global biosimilars and oncology biosimilars mar

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World
  • Market Size

Biosimilar Market Outlook, By Region (2013-2022) ($MN) ## Global Biosimilar Market Outlook, By Product (2013-2022) ($MN) ## Global Biosimilar Market Outlook, By Peptides (2013-2022) ($MN) ## Global Biosimilar Market Outlook, By Erythropoietin (2013-2022) ($MN) ## Glob

  • Biosimilar
  • Asia
  • Europe
  • World
  • Forecast

Global Biosimilar Insulin Market Overview ##. ## Preface to Biosimilar Insulin Market ##. ## Biosimilar Competition Assessment ##.

  • Biosimilar
  • Insulin
  • Therapy
  • World
  • Market Size

Insulin Biosimilars - Global Market Outlook (2016-2022) ## Executive Summary ## Preface ##. ## Abstract ##. ## Stake Holders ##. ## Research Scope ##. ## Research Methodology ##. ##. ## Data Mining ##. ##. ## Data Analysis ##. ##. ## Data Validation ##. ##. ## Research Approach ##. ## Research Sources ##. ##. ## Primary Research S

  • Biosimilar
  • Asia
  • Europe
  • World
  • Forecast

Will your biosimilar face a price cap?

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • India

Biosimilars: a quick snapshot of the current market ##. ## Strategic reasons for investing in the biosimilars market ##. ## Sizing the current biosimilars opportunity ##. ## The current commercial landscape for biosimilars ##. ## A summary of the current biosimilars

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug

Growth Opportunity and Market Forecast of Key Biosimilars—Rheumatoid Arthritis Growth Opportunity and Market Forecast of Key Biosimilars—Rheumatoid Arthritis Top-selling Biotech drugs Growth Opportunities in Rheumatoid Arthritis Etanercept Biosimilars—Adoption Rate Etanerc

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Europe
  • Forecast

Japan Biosimilars – A start of Authorized Biosimilar Era?

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Japan